19 Nov 2026, 10:42
Company AdministrationMS
Announcement history available from 1 August 2025
| Date / Time | Heading | Type | MS | Report Codes | |
|---|---|---|---|---|---|
| 19 Nov 2026, 10:42 | Release of Securities from Escrow | Company Administration | MS | 06009, 12008 | |
| 17 Nov 2026, 09:18 | First patient in India receives NervAlign Nerve Cuff | Company Update | MS | 11001 | |
| 2 Nov 2026, 10:36 | Quarterly Investor Presentation | Presentations | — | 03026 | |
| 28 Oct 2026, 15:58 | Becoming a substantial holder | Substantial Holders | — | 02001 | |
| 28 Oct 2026, 13:56 | Notification regarding unquoted securities - RNV | Securities Administration | — | 06021 | |
| 26 Oct 2026, 09:53 | Quarterly Report Webinar | Presentations | — | 14014 | |
| 26 Oct 2026, 09:52 | Q1 FY27 Activities Report and Appendix 4C | Quarterly Reports | MS | 19001, 19006 | |
| 19 Oct 2026, 09:20 | Positive 12-Month Data for NervAlign Nerve Guide Matrix | Company Update | MS | 11001 | |
| 14 Oct 2026, 09:28 | Positive FDA Feedback on NervAlign Nerve Guide Matrix | Company Update | MS | 11001 | |
| 6 Oct 2026, 13:34 | Change of Director's Interest Notice - P Savage | Director Interests | — | 02009 | |
| 6 Oct 2026, 13:34 | Change of Director's Interest Notice - M McGuire | Director Interests | — | 02009 | |
| 6 Oct 2026, 13:33 | Change of Director's Interest Notice - J Chick | Director Interests | — | 02009 | |
| 6 Oct 2026, 13:18 | Cleansing Notice | Securities Administration | — | 06018 | |
| 6 Oct 2026, 13:14 | Application for quotation of securities - RNV | Securities Administration | — | 06020 | |
| 6 Oct 2026, 09:53 | Proposed issue of securities - RNV | Securities Administration | — | 06013 | |
| 6 Oct 2026, 09:50 | Notification regarding unquoted securities - RNV | Securities Administration | — | 06021 | |
| 5 Oct 2026, 15:11 | Results of Meeting | Meetings & Governance | — | 08003 | |
| 5 Oct 2026, 13:20 | ReNerve AGM Presentation | Presentations | MS | 03026, 15002 | |
| 21 Sept 2026, 09:08 | ReNerve completes first cases in Hong Kong and Malaysia | Company Update | MS | 11001 | |
| 14 Sept 2026, 10:35 | Change in substantial holding - J Chick | Substantial Holders | — | 02002 | |
| 14 Sept 2026, 10:19 | Change of Director's Interest Notice - J Chick | Director Interests | — | 02009 | |
| 7 Sept 2026, 09:22 | ReNerve and RMIT awarded $499k grant | Company Update | MS | 11001 | |
| 3 Sept 2026, 09:49 | Notice of Annual General Meeting/Proxy Form | Meetings & Governance | — | 08001, 08004 | |
| 28 Aug 2026, 09:42 | ReNerve - Corporate Governance Statement | Company Administration | — | 03024 | |
| 28 Aug 2026, 09:41 | ReNerve - Appendix 4G | Company Administration | — | 03025 | |
| 28 Aug 2026, 09:40 | ReNerve - Full Year Results | Financial Results | — | 03003, 03014 | |
| 28 Aug 2026, 09:39 | ReNerve - 2026 Annual Report | Financial Results | — | 03001, 03002, 03011, 03012, 03013, 03020 | |
| 28 Aug 2026, 09:35 | ReNerve - Appendix 4E | Financial Results | MS | 03003 | |
| 25 Aug 2026, 12:59 | Cleansing Notice | Securities Administration | — | 06018 | |
| 25 Aug 2026, 12:54 | Application for quotation of securities - RNV | Securities Administration | — | 06020 | |
| 25 Aug 2026, 09:09 | Proposed issue of securities - RNV | Securities Administration | — | 06013 | |
| 19 Aug 2026, 10:38 | Quarterly Investor Presentation | Presentations | MS | 03026 | |
| 12 Aug 2026, 10:16 | Quarterly Investor Webinar | Presentations | — | 12008, 14014 | |
| 10 Aug 2026, 10:44 | ReNerve Secures Marketing Approval in India | Company Update | MS | 11001 | |
| 6 Aug 2026, 10:06 | ReNerve Secures Marketing Approval in the Philippines | Company Update | MS | 11001 | |
| 3 Aug 2026, 11:17 | Change of Director's Interest Notice - J Chick | Director Interests | — | 02009 | |
| 29 July 2026, 09:24 | Q4 FY26 Activities Report and Appendix 4C | Quarterly Reports | MS | 19004, 19009 | |
| 13 July 2026, 14:01 | Notification regarding unquoted securities - RNV | Securities Administration | — | 06021 | |
| 9 July 2026, 09:14 | Proposed issue of securities - RNV | Securities Administration | — | 06013 | |
| 9 July 2026, 09:05 | ReNerve Secures up to A$5 Million Funding Facility | Capital Raising | MS | 03022, 06009 | |
| 6 July 2026, 10:11 | ReNerve Secures Marketing Approval in Indonesia | Company Update | MS | 11001 | |
| 16 June 2026, 09:02 | Notification of cessation of securities - RNV | Securities Administration | — | 06027 | |
| 16 June 2026, 09:01 | Clarification of Key Terms STC Distribution Agreement | Company Update | — | 11001 | |
| 11 June 2026, 09:47 | ReNerve appoints J4 as second Empliq manufacturing partner | Company Update | MS | 11001 | |
| 5 June 2026, 09:15 | ReNerve appoints distribution partner for Malaysian Market | Company Update | MS | 11001 | |
| 1 June 2026, 09:44 | New distribution agreement for broader Hong Kong market | Company Update | MS | 11001 | |
| 8 May 2026, 10:02 | Quarterly Investor Presentation | Presentations | MS | 03026 | |
| 1 May 2026, 11:00 | Quarterly Investor Webinar | Presentations | — | 14014 | |
| 1 May 2026, 09:11 | Notification of cessation of securities - RNV | Securities Administration | — | 06027 | |
| 30 Apr 2026, 09:53 | Final Director's Interest Notice - D Rhodes | Director Interests | — | 02010 |